Filter Results
:
(203)
Show Results For
-
All HBS Web
(1,788)
- Faculty Publications (203)
Show Results For
-
All HBS Web
(1,788)
- Faculty Publications (203)
- June 2021 (Revised October 2021)
- Case
Nissan's Response to the COVID-19 Pandemic
By: Ananth Raman, William Schmidt and Ann Winslow
In January 2020, Ashwani Gupta took over as COO at Nissan Motor Corporation, and several weeks later, the COVID-19 pandemic began. Nissan’s Business Continuity Plan (BCP) had been key to the resilience of Nissan’s supply chain. It had enabled Nissan to recover from...
View Details
Keywords:
Operations;
Supply Chain Management;
Health Pandemics;
Auto Industry;
Manufacturing Industry;
Japan;
India
Raman, Ananth, William Schmidt, and Ann Winslow. "Nissan's Response to the COVID-19 Pandemic." Harvard Business School Case 621-057, June 2021. (Revised October 2021.)
- June 10, 2021
- Article
Preparing Hospitals for the Next Pandemic
By: Regina E. Herzlinger and Barak D. Richman
The COVID-19 epidemic response has shown that the U.S. is blessed with heroic physicians and other health care providers, researchers, and facilities. But it has also revealed a health care system that was woefully unprepared for the surge of pandemic patients. In the...
View Details
Keywords:
Hospital;
Hospital Management;
Hospitals—administration;
Health Care;
Health Care Industry;
Health Care Investment;
Health Care Operations;
Health Pandemics;
Health Care and Treatment;
Operations;
Performance Improvement;
Investment;
Health Industry;
United States
Herzlinger, Regina E., and Barak D. Richman. "Preparing Hospitals for the Next Pandemic." Harvard Business Review Digital Articles (June 10, 2021).
- June 2021
- Case
uBiome
By: Thomas R. Eisenmann and Olivia Graham
uBiome provided clinical tests that sequenced the DNA of human microbiome samples, providing data on health conditions directly to consumers or to prescribing physicians. Founded in 2012, the San Francisco-based startup raised $105 million from top-tier venture capital...
View Details
- 2021
- Working Paper
Nonbank Lending and Credit Cyclicality
By: Quirin Fleckenstein, Manasa Gopal, German Gutierrez and Sebastian Hillenbrand
We document three facts about nonbank lending in the syndicated loan market. First, nonbank lending is more than twice as cyclical as bank lending. Second, declines in nonbank lending explain most of the declines in syndicated lending during the Great Recession and...
View Details
Keywords:
Nonbank Lending;
Credit Cycles;
CLO;
Mutual Funds;
Leveraged Lending;
COVID-19;
Great Migration;
Non-bank Financial Institutions;
Financing and Loans;
Business Cycles
Fleckenstein, Quirin, Manasa Gopal, German Gutierrez, and Sebastian Hillenbrand. "Nonbank Lending and Credit Cyclicality." Working Paper, June 2021.
- 2021
- Working Paper
Financial Flexibility and Corporate Employment
By: Rebecca Lester, Ethan Rouen and Braden Williams
We study the role of financial flexibility on COVID-19 employment actions. Using daily data from March through May 2020 for 354 of the largest U.S. employers, we find that firms facing a negative demand shock were 28.8 percentage points more likely to reduce their...
View Details
Keywords:
Financial Flexibility;
COVID-19;
Pandemic;
Employment;
Health Pandemics;
System Shocks;
Finance
Lester, Rebecca, Ethan Rouen, and Braden Williams. "Financial Flexibility and Corporate Employment." Harvard Business School Series in Accounting and Control, No. 21-119, April 2021.
- April 17, 2021
- Article
Reimagining India's Health System: A Lancet Citizens' Commission
By: Vikram Patel, Kiran Mazumdar-Shaw, Gagandeep Kang, Pamela Das and Tarun Khanna
This commentary announces the launch of the Lancet Citizens’ Commission on Reimagining India’s Health System. The Commission is an ambitious, cross-sectoral effort to develop a citizens’ roadmap to achieving universal health coverage (UHC) in India in the next decade....
View Details
Patel, Vikram, Kiran Mazumdar-Shaw, Gagandeep Kang, Pamela Das, and Tarun Khanna. "Reimagining India's Health System: A Lancet Citizens' Commission." Lancet 397, no. 10283 (April 17, 2021). (Comment.)
- April 2021 (Revised December 2023)
- Case
The Mahindra Group: Leading with Purpose
By: Ranjay Gulati and Rachna Tahilyani
India headquartered Mahindra Group is a multibillion-dollar federation of companies operating across the globe. It is ahead of its time in articulating its purpose and mapping its values, something it had first done at inception and then refreshed yet again as ‘Rise’...
View Details
Keywords:
Mission and Purpose;
Organizational Culture;
Change Management;
Communication Strategy;
Family Ownership;
Corporate Social Responsibility and Impact;
Revenue;
Financial Services Industry;
Financial Services Industry;
Financial Services Industry;
Financial Services Industry;
Asia;
India;
Mumbai;
South Korea;
Italy;
United States
Gulati, Ranjay, and Rachna Tahilyani. "The Mahindra Group: Leading with Purpose." Harvard Business School Case 421-091, April 2021. (Revised December 2023.)
- March 2021
- Case
P.F. Chang's
By: Ashish Nanda, Nitin Nohria and Margaret Cross
Excited yet apprehensive after being named CEO of P.F. Chang’s beginning July 1st, 2020, Damola Adamolekun was well aware of the extraordinary challenges facing the firm. The closure of businesses deemed “nonessential” owing to the COVID-19 pandemic had devastated the...
View Details
Keywords:
Restaurants;
COVID-19 Pandemic;
Scenario Planning;
Scenarios;
Health Pandemics;
Risk and Uncertainty;
Strategy
Nanda, Ashish, Nitin Nohria, and Margaret Cross. "P.F. Chang's." Harvard Business School Case 721-380, March 2021.
- March 2021
- Case
Yale Investments Office: November 2020
By: Josh Lerner, Jo Tango and Alys Ferragamo
David Swensen and the Investments Office staff must decide whether to continue to allocate the bulk of the university's endowment to illiquid investments—hedge funds, private equity, venture capital, real estate, natural resources—given the impact of the COVID-19...
View Details
Keywords:
University Endowment;
Asset Allocation;
Real Estate;
Equities;
Fixed Income;
COVID-19;
Asset Management;
Private Equity;
Venture Capital;
Natural Resources;
Resource Allocation;
Investment;
Investment Portfolio;
Health Pandemics;
Financial Crisis;
Financial Services Industry;
Financial Services Industry;
Financial Services Industry;
Connecticut
Lerner, Josh, Jo Tango, and Alys Ferragamo. "Yale Investments Office: November 2020." Harvard Business School Case 821-074, March 2021.
- February 2021 (Revised May 2021)
- Case
SafeGraph: Selling Data as a Service
By: Ramana Nanda, Abhishek Nagaraj and Allison Ciechanover
Set in January 2021, the CEO of SafeGraph, a four-year-old startup that sold Data as a Service, looked to the future. His aim was to become the most trusted source for data about a physical place. The company provided points of interest (POI) and foot traffic data on...
View Details
Keywords:
Data As A Service;
Monetization;
Pricing;
Business Startups;
Analytics and Data Science;
Consumer Behavior;
Analysis;
Business Model;
Health Pandemics;
Information Industry;
United States
Nanda, Ramana, Abhishek Nagaraj, and Allison Ciechanover. "SafeGraph: Selling Data as a Service." Harvard Business School Case 821-082, February 2021. (Revised May 2021.)
- February 2021
- Supplement
HNA Group: Global Excellence with Chinese Characteristics (C)
By: William C. Kirby, Billy Chan and John P. McHugh
July 2017 was supposed to be a triumphant month for HNA Group. The latest Fortune Global 500 list showed the company had again skyrocketed in its ranking to no. 170, an improvement of over 200 positions from the year prior. Yet earlier that same July, the mysterious...
View Details
Keywords:
Conglomerate;
Airline Industry;
Coronavirus;
Financial Risk;
Debt;
Bankruptcy;
Global Strategy;
Restructuring;
Health Pandemics;
Financial Markets;
Organizational Change and Adaptation;
Financial Condition;
Globalized Firms and Management;
Business and Government Relations;
Financial Services Industry;
Financial Services Industry;
China
Kirby, William C., Billy Chan, and John P. McHugh. "HNA Group: Global Excellence with Chinese Characteristics (C)." Harvard Business School Supplement 321-123, February 2021.
- February 2021 (Revised March 2023)
- Supplement
The Coronavirus (COVID-19) Pandemic and the Global Economy (B)
By: Alberto Cavallo and Christian Godwin
By December 2020, the COVID-19 pandemic had swept across the globe, creating widespread disruption in all aspects of everyday life. Almost 90 million people had been infected and nearly two million had died from the disease. By this point in the pandemic—a year since...
View Details
Keywords:
COVID-19 Pandemic;
Economy;
Health Pandemics;
Economic Slowdown and Stagnation;
Global Range;
Crisis Management;
Disruption
Cavallo, Alberto, and Christian Godwin. "The Coronavirus (COVID-19) Pandemic and the Global Economy (B)." Harvard Business School Supplement 721-434, February 2021. (Revised March 2023.)
- January 2021
- Supplement
Aster DM Healthcare: Budget Exercise
By: V.G. Narayanan and Amy Klopfenstein
In April 2020, Alisha Moopen, Deputy Managing Director of Aster DM Healthcare, a network of clinics, hospitals, and pharmacies in the Middle East and India, must create her company’s budget for the 2021 fiscal year in light of the onset of Covid-19. The pandemic had...
View Details
Keywords:
Decision Making;
Decisions;
Forecasting and Prediction;
Judgments;
Decision Choices and Conditions;
Cost vs Benefits;
Finance;
Borrowing and Debt;
Financial Institutions;
Banks and Banking;
Financial Condition;
Financial Liquidity;
Accounting;
Budgets and Budgeting;
Management;
Crisis Management;
Health Pandemics;
Health Industry;
Asia;
India;
United Arab Emirates;
Dubai
- January 2021 (Revised May 2021)
- Case
Delta Air Lines: Navigating the COVID-19 Storm
By: Ted Berk and Ryan Flamerich
This case examines Delta Air Lines’ response as demand for its services plummeted in the face of the COVID-19 pandemic, with a focus on the company’s funding needs and capital structure. Following a series of initial actions, the company’s cash “burn” had reduced from...
View Details
Keywords:
COVID-19;
Health Pandemics;
Financial Condition;
Capital Structure;
Crisis Management;
Risk Management;
Business and Stakeholder Relations;
Air Transportation Industry
Berk, Ted, and Ryan Flamerich. "Delta Air Lines: Navigating the COVID-19 Storm." Harvard Business School Case 221-063, January 2021. (Revised May 2021.)
- Article
The Unprecedented Stock Market Reaction to COVID-19
By: Scott Baker, Nicholas Bloom, Steven J. Davis, Kyle Kost, Marco Sammon and Tasaneeya Viratyosin
No previous infectious disease outbreak, including the Spanish Flu, has impacted the stock market as forcefully as the COVID-19 pandemic. In fact, previous pandemics left only mild traces on the U.S. stock market. We use text-based methods to develop these points with...
View Details
Baker, Scott, Nicholas Bloom, Steven J. Davis, Kyle Kost, Marco Sammon, and Tasaneeya Viratyosin. "The Unprecedented Stock Market Reaction to COVID-19." Review of Asset Pricing Studies 10, no. 4 (December 2020): 742–758.
- November 2020
- Teaching Note
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
Teaching Note for HBS Case No. 221-031. When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA)...
View Details
- November 2020
- Supplement
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage...
View Details
- November 2020
- Case
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage...
View Details
Keywords:
Mergers and Acquisitions;
Value;
Valuation;
Judgments;
Decision Making;
Cash Flow;
Financial Instruments;
Cognition and Thinking;
Pharmaceutical Industry;
Biotechnology Industry;
United States
Esty, Benjamin C., and Daniel Fisher. "Valuing Celgene's CVR." Harvard Business School Case 221-031, November 2020.
- 2020
- Working Paper
Revenue Collapses and the Consumption of Small Business Owners in the Early Stages of the COVID-19 Pandemic
By: Olivia S. Kim, Jonathan A. Parker and Antoinette Schoar
Using detailed transaction-level data from financial accounts, this paper shows that the revenues of small businesses and the consumption spending of their owners both decline by roughly 40% following the declaration of the national emergency in March 2020. However,...
View Details
Kim, Olivia S., Jonathan A. Parker, and Antoinette Schoar. "Revenue Collapses and the Consumption of Small Business Owners in the Early Stages of the COVID-19 Pandemic." NBER Working Paper Series, No. 28151, November 2022.
- Fall 2020
- Article
Business Credit Programs in the Pandemic Era
By: Samuel G. Hanson, Jeremy C. Stein, Adi Sunderam and Eric Zwick
We develop a pair of models that speak to the goals and design of the sort of business-lending and corporate-bond purchase programs that have been introduced by governments in response to the ongoing COVID-19 pandemic. An overarching theme is that, in contrast to the...
View Details
Keywords:
COVID-19;
Business Lending;
Government Intervention;
Econometric Models;
Health Pandemics;
Credit;
Governance;
Policy
Hanson, Samuel G., Jeremy C. Stein, Adi Sunderam, and Eric Zwick. "Business Credit Programs in the Pandemic Era." Brookings Papers on Economic Activity (Fall 2020).